세포 증식 시장 규모, 점유율, 성장 분석 : 제품 유형별, 세포 유형별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)

Cell Expansion Market size was valued at USD 33.53 Billion in 2024 and is poised to grow from USD 36.98 Billion in 2025 to USD 81.02 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The market for cell expansion is significantly driven by advancements in solutions that enhance efficiency in cell therapy, gene therapy, and biological therapy development, reducing manpower and costs while delivering reliable results. Key market players are broadening their product offerings to address the surging global demand for these therapies. The adoption of single-use systems (SUS) is revolutionizing cell therapy production by minimizing cross-contamination risks and enhancing cell density while lowering long-term costs. Increased investments from both private and government sectors, along with initiatives promoting cellular therapies, are propelling market growth. Additionally, the push for serum-free media to ensure product quality is gaining traction, further solidifying the prominence of cellular therapies in the life sciences arena and driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Expansion market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Expansion Market Segments Analysis

Global Cell Expansion Market is segmented by Product, Cell Type, Application, End Use and region. Based on Product, the market is segmented into Consumables, Culture Flasks and Accessories and Instruments. Based on Cell Type, the market is segmented into Mammalian, Microbial and Others. Based on Application, the market is segmented intobiopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research and Others. Based on End Use, the market is segmented into Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Expansion Market

The growing application of cell expansion techniques in biopharmaceutical development serves as a significant catalyst for market growth. Biopharmaceuticals, including monoclonal antibodies, vaccines, and cell-based therapies, depend on intricate and scalable cell expansion processes. As chronic diseases become more prevalent and the demand for personalized medicine rises globally, there is an increasing necessity for high-quality biopharmaceutical products. This heightened focus on innovative therapies drives investments in advanced cell expansion technologies, fostering advancements and enhancing production efficiency. Consequently, this trend not only supports the development of effective treatments but also contributes to the overall expansion of the cell expansion market.

Restraints in the Cell Expansion Market

One significant constraint impacting the cell expansion market is the array of regulatory and ethical challenges associated with cell-based therapeutic technologies. The process of developing and marketing cell-based products necessitates adherence to stringent regulatory standards, which can differ dramatically between various regions. Additionally, ethical dilemmas surrounding the utilization of embryonic stem cells and the application of gene editing techniques pose further difficulties, potentially stifling research and development efforts. These factors combine to create a complex landscape that can slow progress and innovation within the sector, making it essential for stakeholders to navigate these obstacles effectively.

Market Trends of the Cell Expansion Market

The Cell Expansion market is witnessing a significant shift towards innovative 3D cell culture and bioreactor technologies, driven by the need for more accurate and physiologically relevant cellular environments. This transition from traditional 2D culture systems enhances cell function, survival, and reproducibility, making it a vital asset in regenerative medicine, oncology, and drug discovery. As researchers and clinicians recognize the limitations of conventional methods, investments in advanced culture techniques are surging to support more predictive models of human physiology. This trend reflects the broader demand for high-fidelity systems that can streamline the drug development process and improve therapeutic outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Expansion Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Reagents, Media, & Serum
  • Other Consumables
• Culture Flasks and Accessories
  • Tissue Culture Flasks
  • Bioreactor Accessories
  • Other Culture Flasks and Accessories
• Instruments
  • Automated Cell Expansion Systems
  • Cell Counters
  • Centrifuges
  • Bioreactors
  • Other Instruments

Global Cell Expansion Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Mammalian
  • Human
  • Stem Cells (SCs)
  • Adult SCs
  • Embryonic SCs
  • Induced Pluripotent SCs
  • Differentiated Cells
  • Animal
• Microbial
• Others

Global Cell Expansion Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Gene Therapy
• Cancer Research
• Stem Cell Research
• Others

Global Cell Expansion Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical & Biotechnology Companies
• Research Institutes
• Cell Banks
• Others

Global Cell Expansion Market Size & CAGR (2026-2033)

• North America (Product, Cell Type, Application, End Use)
  • US
  • Canada
• Europe (Product, Cell Type, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius Stedim Biotech SA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RepliCel Life Sciences (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexImmune Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celltainer Biotech BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations